MedPath

Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response

Not Applicable
Completed
Conditions
Hypertrophic Cardiomyopathy
Mechanical Hyper-synchronicity
Registration Number
NCT02559726
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

Hypertrophic cardiomyopathy (HCM) is a common genetic cardiovascular disease. Outflow-tract gradient of 30 mmHg or more under resting conditions is an independent determinant of symptoms of progressive heart failure and death.

The investigators hypothesize that the electrical approach by dual chamber pacing could improve symptoms and reduce outflow-tract obstruction in a specific sub-group of selected patients with a mechanical hyper-synchronicity. The aim of the study is to identify and describe this phenomenon in HCM with (O-HCM) and without (NO-HCM) outflow-tract obstruction thanks to innovative multi-imaging approach.

Detailed Description

The concept of physiological ventricular desynchrony was described recently with technics of myocardial deformation analysis applied in animal models. Authors confirmed the existence of a time delay in the contraction of the apical walls before basal walls. In O-HCM, the outflow-tract obstruction could be explained by a mechanical hyper-synchronicity between apical and basal walls. This study aims to describe the possible hyper-synchronized contraction in O-HCM and NO-HCM patients unlike the physiological desynchrony observed in healthy volunteers (HV) For this purpose, three imaging tests will be used at baseline: echocardiography (TEE), magnetic resonance imaging (MRI) with gadolinium enhancement only in HCM, and 3-dimensional electrocardiographic mapping (ECM) combined with computed tomography-scan. No follow-up is planned for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • HCM: Adults aged more than 18 years with sarcomeric hypertrophic cardiomyopathy under optimal medical therapy, isolated septal hypertrophy, sinus rhythm, exploitable acoustic window. For women of childbearing age, effective contraception and required negative pregnancy test.
  • O-HCM : outflow-tract gradient more than 30 mmHg at rest and during exercise
  • NO-HCM : outflow-tract gradient less than 30 mmHg at rest and during exercise
  • HV: Adults aged more than 18 years, without cardiovascular disease. For women of childbearing age, effective contraception and required negative pregnancy test.
Exclusion Criteria
  • HV: unusable acoustic window

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mechanical time delay in contraction between basal and apical walls in TEE and MRI in O-HCM, NO-HCM and healthy volunteersDay 1

The main interest variable is the delay value (ms) of the contraction between basal and apical walls measured by TEE and MRI.

Secondary Outcome Measures
NameTimeMethod
Delay between the beginning of the apical and basal circumferential deformation in MRIDay 1
Electrical time delay in ECM between basal and apical walls and relationship with hyper-synchronicity and outflow tract gradient.Day 1
Mechanical time delay between septal and lateral walls in MRI and TEE.Day 1
Apical-basal phase on a phase analysis of the radial displacement data in MRIDay 1
Twist angle between the base and the apex in MRIDay 1
Relationship between each mesure with hyper-synchronicity and outflow-tract gradientDay 1
Delay between peaks of basal and apical radial displacement in MRIDay 1
Delay between the beginning of the apical and basal radial displacement in MRIDay 1
Delay between apical and basal peaks circumferential strain in MRIDay 1
Evolution of mechanical time delay between basal and apical walls at rest and exercise in O-HCM and NO-HCM and relationship with outflow-tract gradient.Day 1

Trial Locations

Locations (1)

CHU de Bordeaux

🇫🇷

Bordeaux, France

CHU de Bordeaux
🇫🇷Bordeaux, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.